vs

Side-by-side financial comparison of Astera Labs, Inc. (ALAB) and Cadre Holdings, Inc. (CDRE). Click either name above to swap in a different company.

Astera Labs, Inc. is the larger business by last-quarter revenue ($270.6M vs $167.2M, roughly 1.6× Cadre Holdings, Inc.). Astera Labs, Inc. runs the higher net margin — 16.6% vs 7.0%, a 9.6% gap on every dollar of revenue. On growth, Astera Labs, Inc. posted the faster year-over-year revenue change (91.8% vs -5.0%). Astera Labs, Inc. produced more free cash flow last quarter ($76.6M vs $18.0M). Over the past eight quarters, Astera Labs, Inc.'s revenue compounded faster (103.6% CAGR vs 10.1%).

Astera Labs, Inc. is an American fabless semiconductor manufacturer and artificial intelligence company. The company specializes in designing high-speed connectivity solutions for data centers and AI infrastructure. The company has been listed on the Nasdaq since March 2024.

RealCadre LLC, commonly Cadre, is an American financial technology company that provides individuals and institutions direct access to real estate investment properties, including commercial properties based in New York. The business and financial press describe it as a platform that "makes the real estate market more like the stock market" by allowing investors to select the individual transactions in which they participate, while investing a smaller amount than would be required to fully fu...

ALAB vs CDRE — Head-to-Head

Bigger by revenue
ALAB
ALAB
1.6× larger
ALAB
$270.6M
$167.2M
CDRE
Growing faster (revenue YoY)
ALAB
ALAB
+96.7% gap
ALAB
91.8%
-5.0%
CDRE
Higher net margin
ALAB
ALAB
9.6% more per $
ALAB
16.6%
7.0%
CDRE
More free cash flow
ALAB
ALAB
$58.6M more FCF
ALAB
$76.6M
$18.0M
CDRE
Faster 2-yr revenue CAGR
ALAB
ALAB
Annualised
ALAB
103.6%
10.1%
CDRE

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ALAB
ALAB
CDRE
CDRE
Revenue
$270.6M
$167.2M
Net Profit
$45.0M
$11.7M
Gross Margin
75.6%
43.4%
Operating Margin
24.7%
12.2%
Net Margin
16.6%
7.0%
Revenue YoY
91.8%
-5.0%
Net Profit YoY
82.0%
-9.6%
EPS (diluted)
$0.25
$0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALAB
ALAB
CDRE
CDRE
Q4 25
$270.6M
$167.2M
Q3 25
$230.6M
$155.9M
Q2 25
$191.9M
$157.1M
Q1 25
$159.4M
$130.1M
Q4 24
$141.1M
$176.0M
Q3 24
$113.1M
$109.4M
Q2 24
$76.8M
$144.3M
Q1 24
$65.3M
$137.9M
Net Profit
ALAB
ALAB
CDRE
CDRE
Q4 25
$45.0M
$11.7M
Q3 25
$91.1M
$10.9M
Q2 25
$51.2M
$12.2M
Q1 25
$31.8M
$9.2M
Q4 24
$24.7M
$13.0M
Q3 24
$-7.6M
$3.7M
Q2 24
$-7.5M
$12.6M
Q1 24
$-93.0M
$6.9M
Gross Margin
ALAB
ALAB
CDRE
CDRE
Q4 25
75.6%
43.4%
Q3 25
76.2%
42.7%
Q2 25
75.8%
40.9%
Q1 25
74.9%
43.1%
Q4 24
74.0%
43.9%
Q3 24
77.7%
36.6%
Q2 24
77.9%
40.6%
Q1 24
77.4%
41.8%
Operating Margin
ALAB
ALAB
CDRE
CDRE
Q4 25
24.7%
12.2%
Q3 25
24.0%
12.0%
Q2 25
20.7%
9.3%
Q1 25
7.1%
10.4%
Q4 24
0.1%
16.7%
Q3 24
-7.9%
5.0%
Q2 24
-31.7%
13.8%
Q1 24
-127.1%
8.7%
Net Margin
ALAB
ALAB
CDRE
CDRE
Q4 25
16.6%
7.0%
Q3 25
39.5%
7.0%
Q2 25
26.7%
7.8%
Q1 25
20.0%
7.1%
Q4 24
17.5%
7.4%
Q3 24
-6.7%
3.3%
Q2 24
-9.8%
8.7%
Q1 24
-142.5%
5.0%
EPS (diluted)
ALAB
ALAB
CDRE
CDRE
Q4 25
$0.25
$0.22
Q3 25
$0.50
$0.27
Q2 25
$0.29
$0.30
Q1 25
$0.18
$0.23
Q4 24
$1.23
$0.32
Q3 24
$-0.05
$0.09
Q2 24
$-0.05
$0.31
Q1 24
$-1.77
$0.18

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALAB
ALAB
CDRE
CDRE
Cash + ST InvestmentsLiquidity on hand
$167.6M
$122.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.4B
$317.8M
Total Assets
$1.5B
$770.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALAB
ALAB
CDRE
CDRE
Q4 25
$167.6M
$122.9M
Q3 25
$140.4M
$150.9M
Q2 25
$162.3M
$137.5M
Q1 25
$86.4M
$133.4M
Q4 24
$79.6M
$124.9M
Q3 24
$126.1M
$93.0M
Q2 24
$421.1M
$105.9M
Q1 24
$696.1M
$87.1M
Stockholders' Equity
ALAB
ALAB
CDRE
CDRE
Q4 25
$1.4B
$317.8M
Q3 25
$1.3B
$340.4M
Q2 25
$1.1B
$332.5M
Q1 25
$1.0B
$317.6M
Q4 24
$964.8M
$311.5M
Q3 24
$889.6M
$300.3M
Q2 24
$845.3M
$299.4M
Q1 24
$808.8M
$270.7M
Total Assets
ALAB
ALAB
CDRE
CDRE
Q4 25
$1.5B
$770.0M
Q3 25
$1.4B
$792.1M
Q2 25
$1.3B
$794.4M
Q1 25
$1.1B
$656.3M
Q4 24
$1.1B
$652.7M
Q3 24
$983.1M
$616.6M
Q2 24
$915.5M
$620.6M
Q1 24
$864.9M
$599.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALAB
ALAB
CDRE
CDRE
Operating Cash FlowLast quarter
$95.3M
$21.3M
Free Cash FlowOCF − Capex
$76.6M
$18.0M
FCF MarginFCF / Revenue
28.3%
10.7%
Capex IntensityCapex / Revenue
6.9%
2.0%
Cash ConversionOCF / Net Profit
2.12×
1.81×
TTM Free Cash FlowTrailing 4 quarters
$281.8M
$56.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALAB
ALAB
CDRE
CDRE
Q4 25
$95.3M
$21.3M
Q3 25
$78.2M
$22.5M
Q2 25
$135.4M
$2.6M
Q1 25
$10.5M
$17.4M
Q4 24
$39.7M
$23.7M
Q3 24
$63.5M
$-5.2M
Q2 24
$29.8M
$11.1M
Q1 24
$3.7M
$2.1M
Free Cash Flow
ALAB
ALAB
CDRE
CDRE
Q4 25
$76.6M
$18.0M
Q3 25
$65.9M
$21.6M
Q2 25
$133.3M
$1.2M
Q1 25
$6.0M
$16.1M
Q4 24
$24.3M
$22.4M
Q3 24
$46.8M
$-6.2M
Q2 24
$28.5M
$9.1M
Q1 24
$228.0K
$794.0K
FCF Margin
ALAB
ALAB
CDRE
CDRE
Q4 25
28.3%
10.7%
Q3 25
28.6%
13.9%
Q2 25
69.5%
0.7%
Q1 25
3.7%
12.4%
Q4 24
17.2%
12.7%
Q3 24
41.4%
-5.7%
Q2 24
37.1%
6.3%
Q1 24
0.3%
0.6%
Capex Intensity
ALAB
ALAB
CDRE
CDRE
Q4 25
6.9%
2.0%
Q3 25
5.3%
0.5%
Q2 25
1.1%
0.9%
Q1 25
2.8%
1.0%
Q4 24
10.9%
0.7%
Q3 24
14.8%
0.9%
Q2 24
1.7%
1.4%
Q1 24
5.2%
1.0%
Cash Conversion
ALAB
ALAB
CDRE
CDRE
Q4 25
2.12×
1.81×
Q3 25
0.86×
2.05×
Q2 25
2.64×
0.21×
Q1 25
0.33×
1.88×
Q4 24
1.61×
1.83×
Q3 24
-1.43×
Q2 24
0.89×
Q1 24
0.31×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ALAB
ALAB

Segment breakdown not available.

CDRE
CDRE

U.s.state And Local Agencies$72.7M43%
Other$48.6M29%
U.s.Federal Agencies$31.6M19%
Commercial$12.0M7%

Related Comparisons